|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.70 SEK | -2.37% |
|
-2.68% | - |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-16 | Affärsvärlden Issues Buy Recommendation for Salix | FW |
| 1 day | -2.37% | ||
| 1 week | -2.68% |
| 1 week | 60.4 |  | 66.9 |
| 1 month | 54.46 | | 66.9 |
| Current year | 54.46 | | 66.9 |
| 1 year | 54.46 | | 66.9 |
| 3 years | 54.46 | | 66.9 |
| 5 years | 54.46 | | 66.9 |
| 10 years | 54.46 | | 66.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Hansson
CEO | Chief Executive Officer | 51 | 01/09/2021 |
Carolina Nerman
DFI | Director of Finance/CFO | 46 | 01/01/2024 |
Christos Selman
PRN | Corporate Officer/Principal | 35 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 01/01/2025 | |
Andreas Stenbäck
BRD | Director/Board Member | 47 | 01/02/2019 |
| Director/Board Member | 58 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-15 | Others | Chairman | 18,581,509 | - | ||
| 06-15 | Others | Executive/Senior Manager | 162,980 | - | ||
| 06-15 | Others | Director | 6,311 | - |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.59B 369M 324M 299M 279M 524M 34.84B 535M 1.39B 17.22B 1.39B 1.36B 59.71B | 4.12B 424M 371M 342M 321M 601M 39.96B 614M 1.59B 19.75B 1.59B 1.56B 68.48B |
| Net income | 90M 9.26M 8.12M 7.49M 7.01M 13.15M 874M 13.42M 34.82M 432M 34.79M 34.03M 1.5B | 190M 19.56M 17.15M 15.81M 14.8M 27.75M 1.85B 28.33M 73.52M 912M 73.45M 71.84M 3.16B |
| Net Debt | - | - |
Employees
650
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | SEK 61.70 | -2.37% | 17,732 |
| 25/06/26 | SEK 63.20 | -1.25% | 37,334 |
| 24/06/26 | SEK 64.00 | 0.00% | 33,158 |
| 23/06/26 | SEK 64.00 | +1.27% | 49,381 |
| 22/06/26 | SEK 63.20 | -0.32% | 82,847 |
- Stock Market
- Stocks
- SALIX Stock
Select your edition
All financial news and data tailored to specific country editions
